Sodium Glucose Co-Transporter 2 Inhibitors
7 clinical trials · Condition
◉ Watch Sodium Glucose Co-Transporter 2 Inhibitors
| Record | Firm | Date |
|---|---|---|
| Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation. (NCT04780438) | G.Gennimatas General Hospital | 2021-09-01 |
| Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention (NCT04806633) | G.Gennimatas General Hospital | 2021-04-01 |
Track Sodium Glucose Co-Transporter 2 Inhibitors automatically
Every clearance here is in the API, with alerts when new ones post.